Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
In contrast to the only person cured of HIV, this man did not have a donor with a genetic abnormality conferring HIV resistance.
5 simple steps to help you understand those attention-grabbing articles and headlines
Researchers are seeking to better understand how early HIV treatment in infants affects the store of latently infected cells.
A look at the most notable HIV-related studies presented at the 2017 Conference on Retroviruses and Opportunistic Infections in Seattle.
Combined with the drug romidepsin, the HIV Conserv vaccine has allowed them to stop HIV meds without a major viral rebound.
So why is he taking meds every day?
A protein that normally blocks HIV from infecting the immune cells naturally deactivates for small windows of time.
The desires to improve health and contribute to science are motivating factors, while concerns about personal risks are deterrents.
Funding will support these 12 research- and community-based projects.
British press publishes false information about HIV cure.
An experimental antibody treatment has led a group of monkeys infected with HIV’s simian cousin into an extended period of viral remission.
After giving such a treatment to two monkeys, researchers found one experienced inflammation in its brain.
Obama signs the biggest health legislation since his Affordable Care Act. What strings are attached?
In a 111-person group of people treated for HIV, the average viral reservoir half-life was 12 years.
The antibody VRC01 proved safe but didn’t do a stellar job of delaying HIV’s rebound after stopping standard antiretroviral treatment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.